Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RISE Life Science was a Canadian cannabis-based health and wellness company that developed botanical and hemp/cannabis consumer products for medical and adult-use markets. The business appears to have focused on branded consumer products and related services rather than a traditional drug-development pipeline. Public descriptions also referenced product development, analytical services, and supply-chain machinery tied to cannabinoid wellness products. In November 2021, RISE completed a reverse-takeover transaction and changed its name to Britannia Life Sciences, so RISE Life Science no longer operates as an independent active company under that name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RISE Life Science.